FDA Early Alert Covers Some Edwards Commander M Systems

The US Food and Drug Administration has issued an early alert involving some Commander M delivery systems used with Edwards Lifesciences’ Sapien M3 transcatheter mitral valve replacement system, according to Insights.

Insights reported that the alert follows reports of balloon ruptures during inflation. Edwards Lifesciences reported three incidents associated with the issue, the publisher said.

Reported incidents and outcomes

Of the three incidents reported by Edwards Lifesciences, one involved a death and one involved a serious injury, according to Insights. The FDA’s early alert concerns some Commander M delivery systems used with the Sapien M3 transcatheter mitral valve replacement system.

Insights characterized the reported device issue as balloon ruptures during inflation. The report identifies the delivery system and its use with the Sapien M3 system as the focus of the FDA alert.

Regulatory and safety update

The early alert is a regulatory and safety development for professionals following transcatheter mitral valve replacement technology. Insights reported that the FDA issued the alert after the balloon-rupture reports and that Edwards Lifesciences reported the three incidents.

The available report is limited to some Commander M delivery systems used with Sapien M3. Insights did not characterize the alert as applying to all Edwards Lifesciences products.

For medical-device sales professionals, the update centers on the FDA alert, the reported balloon ruptures during inflation, and the outcomes reported by Edwards Lifesciences. Communications about the event should distinguish the affected Commander M delivery systems from broader product statements not described in the report.

Source context

Insights reported the FDA’s early alert and Edwards Lifesciences’ report of three incidents, including one death and one serious injury. The publisher linked the incidents to balloon ruptures during inflation involving some Commander M delivery systems used with the Sapien M3 transcatheter mitral valve replacement system.

The report provides a focused account of an FDA safety alert involving a specific delivery-system use. It identifies the reported event, the system involved, and the patient outcomes included in Edwards Lifesciences’ incident report.